Globalization Market Intelligence Market Research Pharmaceutical 
Alpha Sense BI
MARCH 10, 2023
The COVID-19 pandemic has ushered in a seismic shift in the pharmaceutical industry. An increasing number of pharma professionals are relying on market intelligence platforms to stay on top of these movements while providing the tools they need to devise a business or investment strategy.
Netbasequid
APRIL 26, 2023
To succeed, companies must have the capacity to gather and merge multiple consumer and market data sources. And our 2023 Global Consumer Insight Analytics survey report showcases how marketers across various industries leverage consumer research to promote brand recognition and drive business growth.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
BIS Research
NOVEMBER 2, 2018
According to a market intelligence report published by BIS Research, titled ‘ Global NGS Informatics and Clinical Genomics Market – Analysis and Forecast (2018 – 2028) ’, the global market is expected to reach $5885.8 will lead the market with a revenue share of $416.6
ArchIntel
APRIL 21, 2021
While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. She spent two years at KLA as market intelligence manager. As of 2019, there were some 12.8
BIS Research
DECEMBER 20, 2018
The global expenditure on the healthcare was estimated at $7 trillion in 2015. Although, the vaccine market is small as compared to the pharmaceutical market in the healthcare industry but has showcased a better growth rate than the pharmaceutical market. billion in 2017 and is expected to reach $103.57
Alpha Sense BI
JULY 14, 2023
It’s the ideal tool for business professionals looking to implement a qualitative research strategy powered by automated features and proprietary AI search technology. AlphaSense is used by 85% of the S&P 100, 97% of the Dow 30, and 80% of the world’s top consult anc ies.
BIS Research
NOVEMBER 29, 2018
The area of focus for these companies is extensive research and development programs, which can help develop best-in-class therapies for the novel patient experience. Also, as per the records of the global biologics market, it has been revealed that the number of FDA approvals for the biological drugs are increasing year-on-year.
Expert insights. Personalized for you.
96 
Let's personalize your content